Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher S King

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Chest|July 14, 2020
A New Way of Looking at an Old ProblemChristopher S King
Cleveland Clinic Journal of Medicine|August 9, 2007
Bilateral parotitis and facial nerve palsyChristopher S King, Michael Zapor
Disease-A-Month : DM|October 28, 2009
Treatment of sarcoidosisChristopher S King, William Kelly
Current Opinion in Pulmonary Medicine|August 3, 2020
Critical care of patients with pulmonary arterial hypertensionShambhu Aryal, Christopher S King
Chest|May 11, 2020
The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of TreatmentChristopher S King, Oksana A Shlobin
Current Opinion in Pulmonary Medicine|July 13, 2015
Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosisChristopher S King, Steven D Nathan
Respiratory Care|April 23, 2008
Clinical asthma syndromes and important asthma mimicsChristopher S King, Lisa K Moores
Chest|June 14, 2016
POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? YesChristopher S King, Steven D Nathan
Chest|August 5, 2015
Organ Donors: Making the Most of What Is OfferedSteven D Nathan, Christopher S King
The Lancet. Respiratory Medicine|September 8, 2016
Idiopathic pulmonary fibrosis: effects and optimal management of comorbiditiesChristopher S King, Steven D Nathan
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Chest|July 14, 2020
A New Way of Looking at an Old ProblemChristopher S King
Cleveland Clinic Journal of Medicine|August 9, 2007
Bilateral parotitis and facial nerve palsyChristopher S King, Michael Zapor
Disease-A-Month : DM|October 28, 2009
Treatment of sarcoidosisChristopher S King, William Kelly
Current Opinion in Pulmonary Medicine|August 3, 2020
Critical care of patients with pulmonary arterial hypertensionShambhu Aryal, Christopher S King
Chest|May 11, 2020
The Trouble With Group 3 Pulmonary Hypertension in Interstitial Lung Disease: Dilemmas in Diagnosis and the Conundrum of TreatmentChristopher S King, Oksana A Shlobin
Current Opinion in Pulmonary Medicine|July 13, 2015
Practical considerations in the pharmacologic treatment of idiopathic pulmonary fibrosisChristopher S King, Steven D Nathan
Respiratory Care|April 23, 2008
Clinical asthma syndromes and important asthma mimicsChristopher S King, Lisa K Moores
Chest|June 14, 2016
POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? YesChristopher S King, Steven D Nathan
Chest|August 5, 2015
Organ Donors: Making the Most of What Is OfferedSteven D Nathan, Christopher S King
The Lancet. Respiratory Medicine|September 8, 2016
Idiopathic pulmonary fibrosis: effects and optimal management of comorbiditiesChristopher S King, Steven D Nathan
Pageof 10